Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis

NCT04884880 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-05-13

No results posted yet for this study

Summary

The aim of this study is to assess the efficacy and safety of Luo-Fu-Shan Plaster in patients with Rheumatoid Arthritis.

Conditions

  • Arthritis, Rheumatoid

Interventions

DRUG

Luo-Fu-Shan Plaster

Luo-Fu-Shan Plaster 10g,once daily,4 weeks

DRUG

The placebo 10g

Placebo 10g,once daily,4 weeks

Sponsors & Collaborators

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Jiang Quan, PhD · Guang'anmen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-14
Primary Completion
2021-12-31
Completion
2022-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04884880 on ClinicalTrials.gov